# Becton Dickinson Microbiology Systems

- Location (FDA's records): Cockeysville, MD
- FDA decisions: 33 (1992–1999): 33 510(k) clearances
- Product codes: JTN (12), JWY (4), JSO (3), MDB (3), JTO (3), JTZ (2), JSS (2), JSP (1), JST (1), LQL (1), LSL (1)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 8 (0 its own)
- Recalls linked to its devices: 11 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Ab Biodisk: 1 (https://510kreport.com/company/ab-biodisk)
- Innovative Diagnostic Systems, Inc.: 1 (https://510kreport.com/company/innovative-diagnostic-systems)

## Firms that cite its devices most
- Becton, Dickinson & CO: 7 (https://510kreport.com/company/becton-dickinson)
- Edge Biologicals, Inc.: 1 (https://510kreport.com/company/edge-biologicals)

## Its most-cited devices
- K984631: Bdprobetec ET Chlamydia Trachomatis and Neisseria Gonorrhoeae Amplified Dna Assay (1999), cited by 4
- K963036: Mueller Hinton II Broth (Cation-Adjusted) with Lysed Horse Blood (1996), cited by 1
- K970512: Bactec Myco/F Lytic Culture Vials (1998), cited by 1
- K960420: Mueller Hinton Agar with 5% Sheep Blood (1996), cited by 1
- K970333: Bactec Myco/F Lytic Culture Vials (1998), cited by 1

## Recent decisions
- K993577: Cefotaxime/Clavulanic, 30/10UG, BBL Sensi-Disc and Ceftazidime/Clavulanic Acid, 30/10UG, BBL Sensi-Disc (Dec 1, 1999)
- K984631: Bdprobetec ET Chlamydia Trachomatis and Neisseria Gonorrhoeae Amplified Dna Assay (Nov 4, 1999)
- K981517: Cefdinir, 5 UG, Sensi-Disc (Jun 9, 1998)
- K980683: Trovafloxacin 10G, Sensi-Disc (May 1, 1998)
- K974578: Grepafloxacin, 5 MG, Sensi-Disc (Feb 23, 1998)
- K970333: Bactec Myco/F Lytic Culture Vials (Jan 28, 1998)
- K970512: Bactec Myco/F Lytic Culture Vials (Jan 8, 1998)
- K972758: Bactec Myco/F-Sputa Culture Vials (Aug 8, 1997)

Source page: https://510kreport.com/company/becton-dickinson-microbiology-systems